VyraMed, a Fettech company’s Post

We are excited to share the data from the last several months! Please see the attached poster presented by Dr. Jennifer Moffat at #ICAR2024 in Australia. MTP, in both powder and gel form, has been shown to be effective against VZV (Shingles) in human skin organ culture. Remarkably, it even works after day 3. Our broad-spectrum antiviral activity against enveloped viruses has been confirmed in multiple models of VZV. We eagerly anticipate the next steps in this research! #ICAR2024 #ISAR #AntiViralResearch #VyraMed #Fettech #MTPgel

  • No alternative text description for this image

Big thanks to Dr. Megan Gribble Lloyd and Dr. Jennifer Moffat for their hard work in the lab, and thanks to Dr. Heather Greenstone at NIH for sponsoring the work!

See more comments

To view or add a comment, sign in

Explore topics